Service organisation for the secondary prevention of ischaemic heart disease in primary care

Cochrane Database of Systematic Reviews

Volumn 2010, Issue 3, 2010, Pages

  Buckley, Brian S ^a   Byrne, Mary C ^a   Smith, Susan M ^b  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARDIOVASCULAR AGENT; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

BLOOD PRESSURE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL EFFECTIVENESS; CLINICAL OUTCOME; COMMUNITY; CONTROLLED CLINICAL TRIAL (TOPIC); DIET; DIET THERAPY; DYSLIPIDEMIA; EXERCISE; HEALTH CARE ORGANIZATION; HEALTH SERVICE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LIFESTYLE; OBESITY; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT MONITORING; PHYSICIAN; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUASI EXPERIMENTAL STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECALL; REVIEW; RISK FACTOR; SECONDARY PREVENTION; SMOKING; SYSTEMATIC REVIEW; TREATMENT PLANNING; HEART MUSCLE ISCHEMIA; META ANALYSIS; ORGANIZATION AND MANAGEMENT; PRIMARY HEALTH CARE;

HUMANS; MYOCARDIAL ISCHEMIA; PATIENT COMPLIANCE; PRIMARY HEALTH CARE; SECONDARY PREVENTION;

EID: 77951251160     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD006772.pub2     Document Type: Review

References (111)

1. Community Pharmacy Medicines Management Project Evaluation Team. The MEDMAN study: a randomized controlled trial of community pharmacy-led medicines management for patients with coronary heart disease. Family Practice 2007; Vol. 24, issue 2:189-200.
2. Campbell NC, Ritchie LD, Thain J, Deans HG, Rawles JM, Squair JL. Secondary prevention in coronary heart disease: a randomised trial of nurse led clinics in primary care. Heart 1998; Vol. 80, issue 5:447-52.
3. Murchie P, Campbell NC, Ritchie LD, Simpson JA, Thain J. Secondary prevention clinics for coronary heart disease: four year follow up of a randomised controlled trial in primary care. BMJ (Clinical Research Ed.) 2003; Vol. 326, issue 7380:84.
4. Cupples ME, McKnight A. Five year follow up of patients at high cardiovascular risk who took part in randomised controlled trial of health promotion. BMJ (Clinical Research Ed.) 1999;319(7211):687-8.
5. Cupples ME, McKnight A. Randomised controlled trial of health promotion in general practice for patients at high cardiovascular risk. BMJ (Clinical Research Ed.) 1994; Vol. 309, issue 6960:993-6.
6. Cupples ME, McKnight A, O'Neill C, Normand C. The effect of personal health education on the quality of life of patients with angina in general practice. Health Education Journal 1996;55(1):993-6.
7. Eccles M, Grimshaw J, Steen N, Parkin D, Purves I, McColl E, et al.The design and analysis of a randomized controlled trial to evaluate computerized decision support in primary care: the COGENT study. Family Practice 2000;17:180-6.
8. Eccles M, McColl E, Steen N, Rousseau N, Grimshaw J, Parkin D, et al.Effect of computerised evidence based guidelines on management of asthma and angina in adults in primary care: cluster randomised controlled trial. BMJ (Clinical Research Ed.) 2002; Vol. 325, issue 7370:941.
9. Feder G, Griffiths C, Eldridge S, Spence M. Effect of postal prompts to patients and general practitioners on the quality of primary care after a coronary event (POST): randomised controlled trial. BMJ (Clinical Research Ed.) 1999; Vol. 318, issue 7197:1522-6.
10. Gao WG, Hu DY, Ma WL, Tang CZ, Li J, Hasimu B, et al.Effect of health management on the rehabilitation of patients undergoing coronary artery bypass graft. Journal of Clinical Rehabilitative Tissue Engineering Research. China, 2007; Vol. 11, issue 25:4874-8.
11. Kiessling A, Henriksson P. Efficacy of case method learning in general practice for secondary prevention in patients with coronary artery disease: randomised controlled study. BMJ (Clinical Research Ed.) 2002; Vol. 325, issue 7369:877-80.
12. Moher M, Yudkin P, Wright L, Turner R, Fuller A, Schofield T, et al.Cluster randomised controlled trial to compare three methods of promoting secondary prevention of coronary heart disease in primary care. BMJ (Clinical Research Ed.) 2001; Vol. 322, issue 7298:1338.
13. Moher M, Yudkin P, Wright L, Turner R, Fuller A, Schofield T, et al.Cluster randomised controlled trial to compare three methods of promoting secondary prevention of coronary heart disease in primary care. BMJ (Clinical Research Ed.) 2001;322 (7298):1338.
14. Munoz MA, Vila J, Cabaero M, Rebato C, Subirana I, Sala J, et al.Efficacy of an intensive prevention program in coronary patients in primary care, a randomised clinical trial. International Journal of Cardiology 2007; Vol. 118, issue 3:312-20.
15. Jolly K, Bradley F, Sharp S, Smith H, Thompson S, Kinmonth AL, et al.Randomised controlled trial of follow up care in general practice of patients with myocardial infarction and angina: final results of the Southampton heart integrated care project (SHIP). The SHIP Collaborative Group. BMJ (Clinical Research Ed.) 1999; Vol. 318, issue 7185:706-11.
16. Murphy AW, Cupples ME, Smith SM, Byrne M, Byrne MC, Newell J, for the SPHERE study team. Effect of tailored practice and patient care plans on secondary prevention of heart disease in general practice: cluster randomised controlled trial. BMJ (Clinical Research Ed.) 2009;339:b4220.
17. Murphy AW, Cupples ME, Smith SM, Byrne M, Leathem C, Byrne MC. The SPHERE Study. Secondary prevention of heart disease in general practice: Protocol of a randomised controlled trial of tailored practice and patient care plans with parallel qualitative, economic and policy analyses. [ISRCTN24081411]. Current Controlled Trials in Cardiovascular Medicine. United Kingdom, 2005; Vol. 6.
18. Ades PA, Pashkow FJ, Fletcher G, Pina IL, Zohman LR, Nestor JR. A controlled trial of cardiac rehabilitation in the home setting using electrocardiographic and voice transtelephonic monitoring. American Heart Journal 2000;139(3):543-8.
19. Allen JK, Blumenthal RS, Margolis S, Young DR, Miller ER, Kelly K. Nurse case management of hypercholesterolemia in patients with coronary heart disease: results of a randomized clinical trial. American Heart Journal 2002; Vol. 144, issue 4:678-86.
20. Baudet M, Hericotte P, Daugareil C. Improvement of the prognosis of the acute coronary syndromes in Landes by lifestyle modifications [Amelioration du pronostic des syndromes coronaires aigus dans les Landes par la modification de l'hygiene de vie]. Annales de Cardiologie et d'Angeiologie 2006; Vol. 55, issue 4:192-8.
21. Bolman C, de Vries H, van Breukelen G. A minimal-contact intervention for cardiac inpatients: long-term effects on smoking cessation. Preventive Medicine 2002; Vol. 35, issue 2:181-92.
22. Bond CM, Fish A, Porteous TH, Reid JP, Scott A, Antonazzo E. A randomised controlled trial of the effects of note-based medication review by community pharmacists on prescribing of cardiovascular drugs in general practice. International Journal of Pharmacy Practice 2007;15(1):39-46.
23. Brubaker PH, Rejeski WJ, Smith MJ, Sevensky KH, Lamb KA, Sotile WM, et al.A home-based maintenance exercise program after center-based cardiac rehabilitation: effects on blood lipids, body composition, and functional capacity. Journal of Cardiopulmonary Rehabilitation 2000; Vol. 20, issue 1:50-6.
24. Caliani SE, Navas JCB, Gomez-Doblas JJ, Rivera RC, Jimenez BG, Lao MM, et al.Postmyocardial infarction cardiac rehabilitation in low risk patients. Results with a coordinated program of cardiological and primary care. Revista Espanola de Cardiologia 2004; Vol. 57, issue 1:53-9.
25. Carlsson R, Lindberg G, Westin L, Israelsson B. Influence of coronary nursing management follow up on lifestyle after acute myocardial infarction. Heart (British Cardiac Society) 1997; Vol. 77, issue 3:256-9.
26. Carroll DL, Rankin SH, Cooper BA. The effects of a collaborative peer advisor/advanced practice nurse intervention: cardiac rehabilitation participation and rehospitalization in older adults after a cardiac event. The Journal of Cardiovascular Nursing 2007; Vol. 22, issue 4:313-9.
27. Chen W, Guo LH, Li YW, Guo SQ, Li Z. Effect of cognitive education on the physical and psychological rehabilitation of patients with coronary heart disease after interventional therapy. Chinese Journal of Clinical Rehabilitation. China, 2005; Vol. 9, issue 7:1-3.
28. Claesson M, Birgander LS, Jansson JH, Lindahl B, Burell G, Asplund K, et al.Cognitive-behavioural stress management does not improve biological cardiovascular risk indicators in women with ischaemic heart disease: a randomized-controlled trial. Journal of Internal Medicine 2006; Vol. 260, issue 4:320-31.
29. Clark NM, Janz NK, Becker MH, Schork MA, Wheeler J, Liang J, et al.Impact of self-management education on the functional health status of older adults with heart disease. The Gerontologist 1992; Vol. 32, issue 4:438-43.
30. Clark NM, Janz NK, Dodge JA, Anthony SM, Wheeler JRC, Liang J, et al.Self-management of heart disease by older adults assessment of an intervention based on social cognitive theory. Research on Aging 1997; Vol. 19, issue 3:362-82.
31. Clark NM, Janz NK, Dodge JA, Schork MA, Fingerlin TE, Wheeler JR, et al.Changes in functional health status of older women with heart disease: evaluation of a program based on self-regulation. The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences 2000; Vol. 55, issue 2:S117-26.
32. Coull AJ, Taylor VH, Elton R, Murdoch PS, Hargreaves AD. A randomised controlled trial of senior Lay Health Mentoring in older people with ischaemic heart disease: The Braveheart Project. Age and Ageing 2004; Vol. 33, issue 4:348-54.
33. DeBusk RF, Miller NH, Superko HR, Dennis CA, Thomas RJ, Lew HT, et al.A case-management system for coronary risk factor modification after acute myocardial infarction. Annals of Internal Medicine 1994; Vol. 120, issue 9:721-9.
34. de Lusignan S, Hague N, Brown A, Majeed A. An educational intervention to improve data recording in the management of ischaemic heart disease in primary care. Journal of Public Health 2004; Vol. 26, issue 1:34-7.
35. Edworthy SM, Baptie B, Galvin D, Brant RF, Churchill-Smith T, Manyari D, et al.Effects of an enhanced secondary prevention program for patients with heart disease: a prospective randomized trial. Canadian Journal of Cardiology 2007; Vol. 23, issue 13:1066-72.
36. Fihn SD, McDonell MB, Diehr P, Anderson SM, Bradley KA, Au DH, et al.Effects of sustained audit/feedback on self-reported health status of primary care patients. The American Journal of Medicine 2004; Vol. 116, issue 4:241-8.
37. Frasure-Smith N, Lesperance F, Prince RH, Verrier P, Garber RA, Juneau M, et al.Randomised trial of home-based psychosocial nursing intervention for patients recovering from myocardial infarction. Lancet 1997; Vol. 350, issue 9076:473-9.
38. Goff DC, Gu L, Cantley LK, Sheedy DJ, Cohen SJ. Quality of care for secondary prevention for patients with coronary heart disease: results of the Hastening the Effective Application of Research through Technology (HEART) trial. American Heart Journal 2003; Vol. 146, issue 6:1045-51.
39. Grover SA, Lowensteyn I, Joseph L, Kaouache M, Marchand S, Coupal L, et al.Patient knowledge of coronary risk profile improves the effectiveness of dyslipidemia therapy: the CHECK-UP study: a randomized controlled trial. Archives of Internal Medicine 2007; Vol. 167, issue 21:2296-303.
40. Heller RF, Lim L, Valenti L, Knapp J. A randomised controlled trial of community based counselling among those discharged from hospital with ischaemic heart disease. Australian and New Zealand Journal of Medicine 1995; Vol. 25, issue 4:362-4.
41. Jiang X, Sit JW, Wong TK. A nurse-led cardiac rehabilitation programme improves health behaviours and cardiac physiological risk parameters: evidence from Chengdu, China. Journal of Clinical Nursing 2007; Vol. 16, issue 10:1886-97.
42. Jolly K, Taylor R, Lip GY, Greenfield S, Raftery J, Mant J, et al.The Birmingham Rehabilitation Uptake Maximisation Study (BRUM). Home-based compared with hospital-based cardiac rehabilitation in a multi-ethnic population: cost-effectiveness and patient adherence. Health Technology Assessment (Winchester, England) 2007; Vol. 11, issue 35:1-118.
43. Karoff M. Individual outcome-oriented cardiologic rehabilitation treatment [Individuelle ergebnisorientierte kardiologische Rehabilitationsbehandlung]. MMW Fortschritte der Medizin 2000; Vol. 142, issue 3 Suppl:179-82.
44. Karoff M, Roseler S, Lorenz C, Kittel J. Intensified after-care--a method for improving occupational reintegration after myocardial infarct and/or bypass operation [Intensivierte Nachsorge (INA)--ein Verfahren zur Verbesserung der beruflichen Reintegration nach Herzinfarkt und/oder Bypassoperation]. Zeitschrift fur Kardiologie 2000; Vol. 89, issue 5:423-33.
45. Khunti K, Stone M, Paul S, Baines J, Gisborne L, Farooqi A, et al.Disease management programme for secondary prevention of coronary heart disease and heart failure in primary care: a cluster randomised controlled trial. Heart 2007; Vol. 93, issue 11:1398-405.
46. Koren MJ, Hunninghake DB, Alliance I. Clinical outcomes in managed-care patients with coronary heart disease treated aggressively in lipid-lowering disease management clinics: the alliance study. Journal of the American College of Cardiology 2004; Vol. 44, issue 9:1772-9.
47. Lapointe F, Lepage S, Larrivee L, Maheux P. Surveillance and treatment of dyslipidemia in the post-infarct patient: can a nurse-led management approach make a difference?. The Canadian Journal of Cardiology 2006; Vol. 22, issue 9:761-7.
48. Lear SA, Ignaszewski A, Linden W, Brozic A, Kiess M, Spinelli JJ, et al.A randomized controlled trial of an extensive lifestyle management intervention (ELMI) following cardiac rehabilitation: Study design and baseline data. Current Controlled Trials in Cardiovascular Medicine. United Kingdom, 2002; Vol. 3.
49. Lester WT, Grant RW, Barnett GO, Chueh HC. Randomized controlled trial of an informatics-based intervention to increase statin prescription for secondary prevention of coronary disease. Journal of General Internal Medicine: Official Journal of the Society for Research and Education in Primary Care Internal Medicine 2006; Vol. 21, issue 1:22-9.
50. Lichtman JH, Amatruda J, Yaari S, Cheng S, Smith GL, Mattera JA, et al.Clinical trial of an educational intervention to achieve recommended cholesterol levels in patients with coronary artery disease. American Heart Journal 2004; Vol. 147, issue 3:522-8.
51. Masley S, Phillips S, Copeland JR. Group office visits change dietary habits of patients with coronary artery disease-the dietary intervention and evaluation trial (D.I.E.T.). The Journal of Family Practice 2001; Vol. 50, issue 3:235-9.
52. McBride P, Underbakke G, Plane MB, Massoth K, Brown RL, Solberg LI, et al.Improving prevention systems in primary care practices: the Health Education and Research Trial (HEART). The Journal of Family Practice 2000; Vol. 49, issue 2:115-25.
53. Mittag O, China C, Hoberg E, Juers E, Kolenda KD, Richardt G, et al.Outcomes of cardiac rehabilitation with versus without a follow-up intervention rendered by telephone (Luebeck follow-up trial): overall and gender-specific effects. International Journal of Rehabilitation Research. Internationale Zeitschrift fuer Rehabilitationsforschung. Revue Internationale de Recherches de Readaptation 2006; Vol. 29, issue 4:295-302.
54. Nordmann A, Heilmbauer I, Walker T, Martina B, Battegay E. A case-management program of medium intensity does not improve cardiovascular risk factor control in coronary artery disease patients: the Heartcare I trial. The American Journal of Medicine 2001; Vol. 110, issue 7:543-50.
55. Ornstein S, Jenkins RG, Nietert PJ, Feifer C, Roylance LF, Nemeth L, et al.A multimethod quality improvement intervention to improve preventive cardiovascular care: A cluster randomized trial. Annals of Internal Medicine. United States, 2004; Vol. 141, issue 7:523-32.
56. Palomaki A, Miilunpalo S, Holm P, Makinen E, Malminiem K. Effects of preventive group education on the resistance of LDL against oxidation and risk factors for coronary heart disease in bypass surgery patients. Annals of Medicine 2002; Vol. 34, issue 4:272-83.
57. Pedersen L, Johansen S, Eksten L. Smoking cessation among acute heart patients: A randomised intervention project. Ugeskrift for Laeger. Denmark, 2005; Vol. 167, issue 33:3044-7.
58. Quist-Paulsen P, Gallefoss F. Randomised controlled trial of smoking cessation intervention after admission for coronary heart disease. BMJ (Clinical Research Ed.) 2003; Vol. 327:1254.
59. Sheps DS, Frasure-Smith N, Freedland KE, Carney RM. The INTERHEART study: intersection between behavioral and general medicine. Psychosomatic Medicine 2004; Vol. 66, issue 6:797-8.
60. Southard BH, Southard DR, Nuckolls J. Clinical trial of an Internet-based case management system for secondary prevention of heart disease see comments. Journal of Cardiopulmonary Rehabilitation 2003; Vol. 23, issue 5:341-8.
61. van der Elst M, Bouvy ML, de Blaey CJ, de Boer A. Improving pharmacotherapy after myocardial infarction by group academic detailing using feedback data on a patient level. Pharmacotherapy 2006; Vol. 26, issue 2:254-9.
62. Vlek JF, Vierhout WP, Knottnerus JA, Schmitz JJ, Winter J, Wesselingh-Megens AM, et al.A randomised controlled trial of joint consultations with general practitioners and cardiologists in primary care. The British Journal of General Practice: The Journal of the Royal College of General Practitioners 2003; Vol. 53, issue 487:108-12.
63. Wood D, Kotseva K, Connolly S, Jennings C, Mead A, Jones J, et al.Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart diease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial. Lancet 2008; Vol. 371:1999-2012.
64. Wyer SJ, Earll L, Joseph S, Harrison J, Giles M, Johnston M. Increasing attendance at a cardiac rehabilitation programme: An intervention study using the Theory of Planned Behaviour. Coronary Health Care 2001; Vol. 5, issue 3:154-9.
65. Young W, Rewa G, Goodman S. Evaluation of a community-based inner-city disease management program for postmyocardial infarction patients: a randomised controlled trial. CMAJ: Canadian Medical Association Journal 2003; Vol. 169:905-10.
66. Zuckerman IH, Weiss SR, McNally D, Layne B, Mullins CD, Wang J. Impact of an educational intervention for secondary prevention of myocardial infarction on Medicaid drug use and cost. American Journal of Managed Care 2004; Vol. 10, issue 7 Pt 2:493-500.
67. Bowker TJ, Clayton TC, Ingham J, McLennan NR, Hobson HL, Pyke SDM, et al.A British Cardiac Society survey of the potential for the secondary prevention of coronary disease: ASPIRE (Action on Secondary Prevention through intervention to Reduce Events). Heart 1996;75:334-42.
68. Brady AJB, Oliver MA, Pittard JB. Secondary prevention in 24, 431 patients with coronary heart disease: Survey in primary care. BMJ (Clinical Research Ed.) 2001;322(7300):1463.
69. Buckley BS, Murphy AW, Glynn L, Hennigan C. Selection bias in enrolment to a programme aimed at the secondary prevention of ischaemic heart disease in general practice: a cohort study. International Journal of Clinical Practice 2007;61(10):1767-72.
70. Buckley BS, Murphy AW. Do patients with angina alone have a more benign prognosis than patients with a history of acute myocardial infarction, revascularisation or both? Findings from a community cohort study. Heart 2008;95:461-7.
71. Campbell NC, Ritchie LD, Thain J, Deans HG, Rawles JM, Squair JL. Secondary prevention in coronary heart disease: a randomised trial of nurse led clinics in primary care. Heart 1998;80(5):447-52.
72. Campbell NC, Thain J, Deans HG, Ritchie LD, Rawles JM. Secondary prevention in coronary heart disease: baseline survey of provision in general practice. BMJ (Clinical Research Ed.) 1998;316:1430-4.
73. Campbell NC, Thain J, Deans HG, Ritchie LD, Rawles JM, Squair JL. Secondary prevention clinics for coronary heart disease: randomised trial of effect on health. BMJ (Clinical Research Ed.) 1998;316:1434-7.
74. Carroll K, Majeed A, Firth C, Gray J. Prevalence and management of coronary heart disease in primary care: population-based cross-sectional study using a disease register. Journal of Public Health Medicine 2003;25(1):29-35.
75. Clark AM, Hartling L, Vandermeer B, McAlister FA. Meta-Analysis: Secondary Prevention Programs for Patients with Coronary Artery Disease. Annals of Internal Medicine 2005;143:659-72.
76. Higgins JPT, Deeks JJ, Altman DG. Chapter 16: Special topics in statistics. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Chichester (UK): John Wiley & Sons, 2008:495.
77. Higgins JPT, Altman DG on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Chichester (UK): John Wiley & Sons, 2008.
78. Cupples ME, McKnight A. Randomised controlled trial of health promotion in general practice for patients at high cardiovascular risk. BMJ (Clinical Research Ed.) 1994;309:993-6.
79. Cupples ME, McKnight A. Five year follow up of patients at high cardiovascular risk who took part in randomised controlled trial of health promotion. BMJ (Clinical Research Ed.) 1999;319:687-8.
80. Davies MJ, Heller S, Skinner TC, Campbell MJ, Carey ME, Cradock S, et al.Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial. BMJ (Clinical Research Ed.) 2008 April 19;336:491-5.
81. De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, et al.European guidelines on cardiovascular disease prevention in clinical practice. European Journal of Cardiovascular Prevention and Rehabilitation 2003;10(Suppl 1):S1-S78.
82. Department of Health and Children, Ireland. Building healthier hearts. Introduction to the report of the Cardiovascular Health Strategy Group. Dublin: Stationery Office, 1999.
83. Donaldson MS, Yordy KD, Lohr KN, Vanselow NA. Primary Care: America's Health in a New Era. Washington DC: National Academy Press, 1996.
84. Doumit G, Gattellari M, Grimshaw J, O'Brien MA. Local opinion leaders: effects on professional practice and health care outcomes. Cochrane Database of Systematic Reviews 2007, Issue 1. [DOI: 10.1002/14651858.CD000125.pub3].
85. Ebrahim S, Beswick A, Burke M, Davey Smith G. Multiple risk factor interventions for primary prevention of coronary heart disease. Cochrane Database of Systematic Reviews 2006, Issue 4. [DOI: 10.1002/14651858.CD001561.pub2].
86. Flanagan DEH, Cox P, Paine D, Davies J, Armitage M. Secondary prevention of coronary heart disease in primary care: a healthy heart initiative. QJM: Monthly Journal of the Association of Physicians 1999;92:945-50.
87. Forsetlund L, Bjorndal A, Rashidian A, Jamtvedt G, O'Brien MA, Wolf F, et al.Continuing education meetings and workshops: effects on professional practice and health care outcomes. Cochrane Database of Systematic Reviews 2009, Issue 2. [DOI: 10.1002/14651858.CD003030.pub2].
88. Health Development Agency. Health Update: Coronary Heart Disease and Stroke. London: Health Development Agency, 2000.
89. Hickling J, Rogers S, Nazereth I. Barriers to detecting and treating hypercholesterolaemia in patients with ischaemic heart disease: primary care perceptions. British Journal of General Practice 2005;55:534-8.
90. Hobbs FDR, Erhardt L. Acceptance of guideline recommendations and perceived implementation of coronary heart disease prevention among primary care physicians in five European countries: the Reassessing European Attitudes about Cardiovascular Treatment (REACT) survey. Family Practice 2002;19:596-604.
91. Jolly K, Bradley F, Sharp S, Smith H, Thompson S, Kinmonth A-L, et al.Randomised controlled trial of follow up care in general practice of patients with myocardial infarction and angina: final results of the Southampton heart integrated care project (SHIP). BMJ (Clinical Research Ed.) 1999;318:706-11.
92. Law M, Watt H, Wald N. The underlying risk of death after myocardial infarction in the absence of treatment. Archives of Internal Medicine 2002;162:2405-10.
93. Majumdar SR, Tsuyuki RT, McAlister FA. Impact of opinion leader?endorsed evidence summaries on the quality of prescribing for patients with cardiovascular disease: A randomized controlled trial. American Heart Journal 2007;153(1):22 e1-8.
94. Mant J, McManus RJ, Hare J, McManus RJ, Hare R. Applicability to primary care of national clinical guidelines on blood pressure lowering for people with stroke: cross sectional study. BMJ (Clinical Research Ed.) 2006;332:635-7.
95. McAlister FA, Lawson FME, Teo KK, Armstrong PW. Randomised trials of secondary prevention programmes in coronary heart disease: systematic review. BMJ (Clinical Research Ed.) 2001;323:957-62.
96. Moher M. Evidence of effectiveness of interventions for secondary prevention and treatment of coronary heart disease in primary care - a review of the literature. Cambridge: Anglia and Oxford Regional Health Authority, 1995.
97. Moher M, Schofield T, Weston S, Fullard E. Managing established coronary heart disease. BMJ (Clinical Research Ed.) 1997;315:69-70.
98. Moher M, Yudkin P, Wright L, Turner R, Fuller A, Schofield T, et al.Cluster randomised controlled trial to compare three methods of promoting secondary prevention of coronary heart disease in primary care. BMJ (Clinical Research Ed.) 2001;322:1-7.
99. Murphy NF, Simpson CR, MacIntyre K, McAlister FA, Chalmers J, McMurray JJV. Prevalence, incidence, primary care burden and medical treatment of angina in Scotland: age, sex and socioeconomic disparities: a population-based study. Heart 2006;92:1047-54.
100. Neal B. Secondary Prevention of Cardiovascular Disease: Fixed Dose Combinations. A Research Agenda for the European Union. In: Laing R editor(s). Priority Medicines for Europe and the World Project: a public health approach to innovation. Geneva: World Health Organization, 2004.
101. Department of Health. National Service Framework for Coronary Heart Disease. London: The Stationery Office, 2000.
102. O'Brien MA, Rogers S, Jamtvedt G, Oxman AD, Odgaard-Jensen J, Kristoffersen DT, et al.Educational outreach visits: effects on professional practice and health care outcomes. Cochrane Database of Systematic Reviews 2007, Issue 4. [DOI: 10.1002/14651858.CD000409.pub2].
103. Ramsay SE, Whincup PH, Lawlor DA, Papacosta O, Lennon LT, Thomas MC, et al.Secondary prevention of coronary heart disease in older patients after the national service framework: population based study. BMJ (Clinical Research Ed.) 2006;332:144-5.
104. Scottish Intercollegiate Guidelines Network. Secondary Prevention of Coronary Heart Disease: A national clinical guideline. Edinburgh: Scottish Intercollegiate Guidelines Network, 2000.
105. Starfield B. Primary care: balancing health needs, services and technology. New York: Oxford University Press, 1998.
106. Julian DG, Bertrand ME, Hjalmarson A, Fox K, Simoons ML, Ceremuzynski L, et al.Management of stable angina pectoris: Recommendations of the Task Force of the European Society of Cardiology. European Heart Journal 1997;18:394-413.
107. Timmis AD, Feder G, Hemmingway H. Prognosis of stable angina pectoris: why we need larger population studies with higher endpoint resolution. Heart 2007;93(7):786-91.
108. World Health Organization. World Health Report 2002: Reducing risk, promoting healthy life. Geneva: World Health Organization, 2002.
109. Williams D, Bennett K, Feely J. Evidence for an age and gender bias in the secondary prevention of ischaemic heart disease in primary care. British Journal of Clinical Pharmacology 2003;55:604-8.
110. Wood D, De Backer G, Faergeman O, Graham I, Mancia G, Pyorala K. Prevention of coronary heart disease in clinical practice: Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. European Heart Journal 1998;19:1434-1503.
111. Wood D, Durrington P, Poulter N. Joint British Recommendations on prevention of coronary heart disease in clinical practice. Heart 1998;80(Suppl 2):S1-29.